Résumé
En France, le cancer du sein est le plus fréquent chez la femme avec une incidence qui ne cesse d’augmenter depuis les deux dernières décennies avec cependant une mortalité à la baisse [1]. Le dépistage systématique a permis un diagnostic d’un nombre plus élevé de cancers du sein de stade précoce et potentiellement curables.
Preview
Unable to display preview. Download preview PDF.
Références
Belot A, Grosclaude P, Bossard N et al. (2008) Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 56: 159–175
Perou CM, Sørlie T, Eisen MB et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747–752
Sørlie T, Perou CM, Tibshirani R et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869–10874
van’ t Veer LJ, Dai H, van de Vijver MJ et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536
Paik S, Shak S, Tang G et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817–2826
Wang Y, Klijn JG, Zhang Y et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671–679
Chang HY, Nuyten DS, Sneddon JB et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102: 3738–3743
Liu R, Wang X, Chen GY et al. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356: 217–226
van Beers EH, Nederlof PM (2006) Array-CGH and breast cancer. Breast Cancer Res 8: 210
Khodarev NN, Beckett M, Labay E et al. (2004) STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 101: 1714–1719
Clarke M, Collins R, Darby S et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087–2106
Bartelink H, Horiot JC, Poortmans P et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378–1387
Dilhuydy JM, Bussieres E, Romestaing P (2001) Radiotherapy of the breast and chest wall: treatment volume. Cancer Radiother 5: 550–559
Fernando IN, Ford HT, Powles TJ et al. (1996) Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 8: 226–233
Karlsson P, Cole BF, Price KN et al. (2007) The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol 25: 2019–2026.
Vicini FA, Kestin L, Huang R et al. (2003) Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 97: 910–919
Elkhuizen PH, van de Vijver MJ, Hermans J et al. (1998) Local recurrence after breastconserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40: 859–867
Arriagada R, Lê MG, Contesso G et al. (2002) Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 13: 1404–413
Arriagada R, Le MG, Guinebretiere JM et al. (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14: 1617–1622
Huston TL, Simmons RM (2005) Locally recurrent breast cancer after conservation therapy. Am J Surg 189: 229–235
Clarke DH, Lê MG, Sarrazin D et al. (1985) Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11: 137–145
Fourquet A, Campana F, Zafrani B et al. (1989) Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17: 719–725
Fisher B, Anderson S, Fisher ER et al. (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338: 327–331
Locker AP, Ellis IO, Morgan DA et al. (1989) Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76: 890–894
Dragun, A.E, Pan J, Rai SN, Kruse B, Jain D (2011) Locoregional Recurrence in Patients With Triple-Negative Breast Cancer: Preliminary Results of a Single Institution Study. Am J Clin Oncol (in press)
Wang SL, Li YX, Song YW et al. (2011) Triple-Negative or HER2-Positive Status Predicts Higher Rates of Locoregional Recurrence in Node-Positive Breast Cancer Patients After Mastectomy. Int J Radiat Oncol Biol Phys (in press)
Solin LJ, Hwang WT, Vapiwala N (2009) Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clin Breast Cancer 9: 96–100
Parikh RR, Yang Q, Higgins SA, Haffty BG (2008) Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys 70: 35–42
Freedman GM, Anderson PR, Tianyu L, Nicolaou N (2009) Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 115: 946–951
Bourgier C et al. (2006) Molecular subclassification and risk of locoregional relapses in early breast cancer patients. San Antonio Breast Cancer Symposium Annual Meeting. Personal Communication, 2006. Abstract 6028.
Truong PT, Lesperance M, Sanghani M et al. (2008) Independent Validation of IBTR ! A Computer-based Tool to Predict Ipsilateral Breast Recurrence in Women with Invasive Breast Cancer Treated with Breast Conserving Surgery. Int J Radiat Oncol Biol Phys 72: #203
Sanghani M, Truong PT, Raad RA et al. (2008) Validation of a Web-based Predictive Nomogram for Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy. Int J Radiat Oncol Biol Phys 72: S91
Nuyten DS, Kreike B, Hart AA et al. (2006) Predicting a local recurrence after breastconserving therapy by gene expression profiling. Breast Cancer Res 8: R62
Weichselbaum RR, Ishwaran H, Yoon T et al. (2008) An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci USA 105: 18490–18495
Kreike B, Halfwerk H, Armstrong N et al. (2009) Local recurrence after breastconserving therapy in relation to gene expression patterns in a large series of patients. Clin Cancer Res 1512: 4181–4190
Nguyen PL, Taghian AG, Katz MS et al. (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26: 2373–2378
Liang K, Lu Y, Jin W et al. (2003) Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2: 1113–1120
Pietras RJ, Poen JC, Gallardo D et al. (1999) Monoclonal antibody to HER-2/ neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res 59: 1347–1355
Sambade MJ, Kimple RJ, Camp JT et al. (2010) Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. Int J Radiat Oncol Biol Phys 77: 575–581
Sambade MJ, Camp JT, Kimple RJ et al. (2009) Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. Radiother Oncol 93: 639–644
Horton JK, Halle J, Ferraro M et al. (2010) Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer with Trastuzumab: A Phase II Trial. Int J Radiat Oncol Biol Phys 76: 998–1004
Collette S, Collette L, Budiharto T et al. (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 ‘boost versus no boost’. Eur J Cancer 44: 2587–2599
Ozsahin M, Ozsahin H, Shi Y et al. (1997) Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys 38: 429–440
Crompton NE, Shi YQ, Emery GC et al. (2001) Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 49: 547–554
Slonina D, Gasinska A (1997) Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J Radiat Biol 72: 693–701
Azria D, Ozsahin M, Kramar A et al. (2008) Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 14: 6284–6288
Ozsahin M, Crompton NEA, Gourgou S et al. (2005) 2005CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 11: 7426–7433
Rights and permissions
Copyright information
© 2012 Springer-Verlag France, Paris
About this paper
Cite this paper
Bourgier, C. (2012). Outils génomiques du choix thérapeutique des cancers du sein. Quelles perspectives à court et moyen terme sur le traitement locorégional. Opinion du radiothérapeute?. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-8178-0245-9_27
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0245-9_27
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0244-2
Online ISBN: 978-2-8178-0245-9